Cargando…

A common gene expression signature in Huntington’s disease patient brain regions

BACKGROUND: Gene expression data provide invaluable insights into disease mechanisms. In Huntington’s disease (HD), a neurodegenerative disease caused by a tri-nucleotide repeat expansion in the huntingtin gene, extensive transcriptional dysregulation has been reported. Conventional dysregulation an...

Descripción completa

Detalles Bibliográficos
Autores principales:	Neueder, Andreas, Bates, Gillian P
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2014
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4219025/ https://www.ncbi.nlm.nih.gov/pubmed/25358814 http://dx.doi.org/10.1186/s12920-014-0060-2

Ejemplares similares

Silencing Srsf6 does not modulate incomplete splicing of the huntingtin gene in Huntington’s disease models
por: Mason, Michael A., et al.
Publicado: (2020)

Common disease signatures from gene expression analysis in Huntington’s disease human blood and brain
por: Mina, Eleni, et al.
Publicado: (2016)

The pathogenic exon 1 HTT protein is produced by incomplete splicing in Huntington’s disease patients
por: Neueder, Andreas, et al.
Publicado: (2017)

Dysfunction of the CNS-Heart Axis in Mouse Models of Huntington's Disease
por: Mielcarek, Michal, et al.
Publicado: (2014)

Optimisation of region-specific reference gene selection and relative gene expression analysis methods for pre-clinical trials of Huntington's disease
por: Benn, Caroline L, et al.
Publicado: (2008)

Huntington’s disease blood and brain show a common gene expression pattern and share an immune signature with Alzheimer’s disease
por: Hensman Moss, Davina J., et al.
Publicado: (2017)

HSF1-dependent and -independent regulation of the mammalian in vivo heat shock response and its impairment in Huntington's disease mouse models
por: Neueder, Andreas, et al.
Publicado: (2017)

Phenotype onset in Huntington’s disease knock‐in mice is correlated with the incomplete splicing of the mutant huntingtin gene
por: Franich, Nicholas R., et al.
Publicado: (2019)

SIRT1 Activity Is Linked to Its Brain Region-Specific Phosphorylation and Is Impaired in Huntington’s Disease Mice
por: Tulino, Raffaella, et al.
Publicado: (2016)

Abnormal molecular signatures of inflammation, energy metabolism, and vesicle biology in human Huntington disease peripheral tissues
por: Neueder, Andreas, et al.
Publicado: (2022)

Novel Isoforms of Heat Shock Transcription Factor 1, HSF1γα and HSF1γβ, Regulate Chaperone Protein Gene Transcription
por: Neueder, Andreas, et al.
Publicado: (2014)

Correction: SIRT1 Activity Is Linked to Its Brain Region-Specific Phosphorylation and Is Impaired in Huntington's Disease Mice
por: Tulino, Raffaella, et al.
Publicado: (2016)

SIRT2 Ablation Has No Effect on Tubulin Acetylation in Brain, Cholesterol Biosynthesis or the Progression of Huntington's Disease Phenotypes In Vivo
por: Bobrowska, Anna, et al.
Publicado: (2012)

Nucleolar stress controls mutant Huntington toxicity and monitors Huntington’s disease progression
por: Sönmez, Aynur, et al.
Publicado: (2021)

Correction: SIRT2 Ablation Has No Effect on Tubulin Acetylation in Brain, Cholesterol Biosynthesis or the Progression of Huntington’s Disease Phenotypes In Vivo
por: Bobrowska, Anna, et al.
Publicado: (2021)

Regulatory mechanisms of incomplete huntingtin mRNA splicing
por: Neueder, Andreas, et al.
Publicado: (2018)

Embryonic Mutant Huntingtin Aggregate Formation in Mouse Models of Huntington’s Disease
por: Osmand, Alexander P., et al.
Publicado: (2016)

Myostatin inhibition prevents skeletal muscle pathophysiology in Huntington’s disease mice
por: Bondulich, Marie K., et al.
Publicado: (2017)

Brain Microbiota in Huntington’s Disease Patients
por: Alonso, Ruth, et al.
Publicado: (2019)

Brain Regions Showing White Matter Loss in Huntington’s Disease Are Enriched for Synaptic and Metabolic Genes
por: McColgan, Peter, et al.
Publicado: (2018)

Correlations of Behavioral Deficits with Brain Pathology Assessed through Longitudinal MRI and Histopathology in the R6/1 Mouse Model of Huntington’s Disease
por: Rattray, Ivan, et al.
Publicado: (2013)

Contesting the dogma of an age-related heat shock response impairment: implications for cardiac-specific age-related disorders
por: Carnemolla, Alisia, et al.
Publicado: (2014)

Genetic Knock-Down of Hdac3 Does Not Modify Disease-Related Phenotypes in a Mouse Model of Huntington's Disease
por: Moumné, Lara, et al.
Publicado: (2012)

The Ubiquitin-Proteasome Reporter GFPu Does Not Accumulate in Neurons of the R6/2 Transgenic Mouse Model of Huntington's Disease
por: Bett, John S., et al.
Publicado: (2009)

Hdac6 Knock-Out Increases Tubulin Acetylation but Does Not Modify Disease Progression in the R6/2 Mouse Model of Huntington's Disease
por: Bobrowska, Anna, et al.
Publicado: (2011)

Brain-Derived Neurotrophic Factor in Patients with Huntington's Disease
por: Zuccato, Chiara, et al.
Publicado: (2011)

Co-expression Patterns between ATN1 and ATXN2 Coincide with Brain Regions Affected in Huntington’s Disease
por: Keo, Arlin, et al.
Publicado: (2017)

Three Huntington’s Disease Specific Mutation-Carrying Human Embryonic Stem Cell Lines Have Stable Number of CAG Repeats upon In Vitro Differentiation into Cardiomyocytes
por: Jacquet, Laureen, et al.
Publicado: (2015)

Metabolic and hormonal signatures in pre-manifest and manifest Huntington's disease patients
por: Wang, Rui, et al.
Publicado: (2014)

Identical oligomeric and fibrillar structures captured from the brains of R6/2 and knock-in mouse models of Huntington's disease
por: Sathasivam, Kirupa, et al.
Publicado: (2010)

Correlations of Behavioral Deficits with Brain Pathology Assessed through Longitudinal MRI and Histopathology in the HdhQ150/Q150 Mouse Model of Huntington’s Disease
por: Rattray, Ivan, et al.
Publicado: (2017)

Characterization of Gastric Mucosa Biopsies Reveals Alterations in Huntington's Disease
por: McCourt, Andrew C, et al.
Publicado: (2015)

Variation within the Huntington's Disease Gene Influences Normal Brain Structure
por: Mühlau, Mark, et al.
Publicado: (2012)

The Huntington's Disease-Related Cardiomyopathy Prevents a Hypertrophic Response in the R6/2 Mouse Model
por: Mielcarek, Michal, et al.
Publicado: (2014)

Supplemental Treatment for Huntington’s Disease with miR-132 that Is Deficient in Huntington’s Disease Brain
por: Fukuoka, Masashi, et al.
Publicado: (2018)

Common gene expression signatures in Parkinson’s disease are driven by changes in cell composition
por: Nido, Gonzalo S., et al.
Publicado: (2020)

Common signatures of differential microRNA expression in Parkinson’s and Alzheimer’s disease brains
por: Dobricic, Valerija, et al.
Publicado: (2022)

In vivo neutralization of the protagonist role of macrophages during the chronic inflammatory stage of Huntington’s disease
por: Pido-Lopez, Jeffrey, et al.
Publicado: (2018)

RNA Sequence Analysis of Human Huntington Disease Brain Reveals an Extensive Increase in Inflammatory and Developmental Gene Expression
por: Labadorf, Adam, et al.
Publicado: (2015)

Genetic Knock-Down of HDAC7 Does Not Ameliorate Disease Pathogenesis in the R6/2 Mouse Model of Huntington's Disease
por: Benn, Caroline L., et al.
Publicado: (2009)

Cannot write session to /tmp/vufind_sessions/sess_ls27g0morm68cvapr5k6epgrmq